Description

Description

Virata (90mg) is an oral antiplatelet tablet formulated with Ticagrelor, a medicine used to help prevent blood clots in patients at risk of serious cardiovascular events. Each pack contains 20 tablets intended for oral use. Virata works by selectively and reversibly inhibiting the P2Y12 receptor on platelets, blocking the binding of adenosine diphosphate and preventing platelets from clumping together to form clots. Unlike some other antiplatelet medicines, Ticagrelor acts in a reversible manner, offering a distinct pharmacological approach to reducing clot formation. Manufactured by CCL Pharmaceuticals, Virata 90mg is commonly prescribed for patients with acute coronary syndrome, including those who have experienced a heart attack or unstable angina, as well as for patients who have undergone procedures such as percutaneous coronary intervention or stent placement, typically used in combination with low-dose aspirin as part of a broader cardiovascular treatment plan.

Ingredients

The active ingredient in Virata 90mg is Ticagrelor, present at a strength of 90mg per tablet. Ticagrelor works by selectively inhibiting the platelet P2Y12 receptor, blocking the binding of adenosine diphosphate and thereby inhibiting platelet aggregation, which helps prevent the formation of harmful blood clots. Alongside the active ingredient, the tablet contains standard pharmaceutical-grade excipients, including fillers, binding agents, and disintegrants, which help maintain the tablet’s structure and support its proper breakdown after being swallowed. The complete excipient list can be found on the package insert or confirmed with a pharmacist, particularly for patients with known sensitivities to certain tablet components.

Dosage Form

Virata 90mg is supplied as an oral tablet, with each pack containing 20 tablets, generally distributed across multiple strips. The tablet is meant to be swallowed whole with water and is not intended for chewing or crushing unless a doctor has specifically advised otherwise. This pack size offers a convenient supply for patients on an ongoing twice-daily dosing schedule as part of their cardiovascular treatment plan.

Uses

Virata 90mg is used to help prevent thrombotic cardiovascular events such as heart attack, stroke, and blood clots within the arteries, particularly in patients diagnosed with acute coronary syndrome. It is often prescribed for individuals who have experienced unstable angina or a heart attack, as well as those who have undergone percutaneous coronary intervention, including the placement of a coronary stent. Virata is typically used in combination with low-dose aspirin, working together to reduce the likelihood of platelets clumping together and forming clots that could block blood flow to the heart or brain. By supporting healthier blood flow and reducing clot risk, this medicine plays an important role in helping to prevent recurrent cardiovascular events in at-risk patients.

How to Use

Virata 90mg should be taken exactly as prescribed by a doctor, typically as one tablet taken twice daily, often in combination with a low daily dose of aspirin as directed by the treating physician. The tablet can generally be taken with or without food and should be swallowed whole with a glass of water. It is important to take this medicine consistently and at regular intervals to maintain its antiplatelet effect, and doses should not be skipped or doubled without medical guidance. Patients should not stop taking Virata abruptly without consulting their doctor, as discontinuing antiplatelet therapy prematurely, particularly after a stent placement, can increase the risk of serious cardiovascular events. Any planned surgical or dental procedures should be discussed with the prescribing doctor in advance, as temporary adjustments to this medicine may be necessary.

Side Effects

As with other antiplatelet medicines, Virata 90mg may cause side effects in some patients, with an increased tendency to bleed or bruise being among the most notable concerns given its mechanism of action. Commonly reported effects include shortness of breath, headache, dizziness, and nosebleeds. Some patients may also experience bleeding gums, easy bruising, or minor bleeding from cuts that takes longer than usual to stop. Less commonly, more significant effects such as fainting, an irregular or fast heartbeat, ringing in the ears, or confusion may occur. In rare but serious cases, symptoms such as black or tarry stools, blood in the urine, severe or uncontrolled bleeding, or significant difficulty breathing may indicate a serious complication requiring immediate medical attention. Any unusual or excessive bleeding should be reported to a doctor promptly.

Pregnancy & Breastfeeding

Virata 90mg should only be used during pregnancy if a doctor determines that the potential benefits outweigh the possible risks, as there is limited data available on the safety of Ticagrelor in pregnant women, and antiplatelet medicines can carry bleeding-related risks during pregnancy and delivery. Women who are pregnant, planning to conceive, or who suspect they may be pregnant should inform their doctor promptly, so that the treatment plan can be carefully reviewed. This medicine is also generally not recommended during breastfeeding unless specifically advised by a doctor, as it is not well established how the active ingredient may transfer into breast milk or affect a nursing infant. A healthcare provider should always be consulted before continuing or adjusting this medicine during pregnancy or breastfeeding.

Storage Instructions

Virata 90mg tablets should be stored below 30 degrees Celsius, protected from heat, direct sunlight, and moisture. The tablets should remain in their original packaging until they are ready to be taken, helping to preserve their stability and effectiveness. As with all medicines, Virata should be kept safely out of the reach and sight of children and pets. Tablets that have passed their expiry date should not be used, and any unused or expired medicine should be disposed of responsibly rather than placed in regular household waste.

FAQs

Q: Why is Virata often prescribed alongside aspirin?
A: Combining Virata with low-dose aspirin provides a more comprehensive antiplatelet effect, which is often necessary for patients with acute coronary syndrome or those who have undergone stent placement, based on your doctor’s specific treatment plan.

Q: Can I stop taking Virata once I feel better?
A: No, this medicine should not be stopped abruptly without medical advice, as doing so, particularly after a stent placement, can significantly increase the risk of serious cardiovascular events such as clot formation within the stent.

Q: What should I do if I notice unusual bleeding or bruising?
A: Mild bruising or minor bleeding that takes slightly longer to stop can be a recognized effect of this medicine, but any severe, persistent, or unexplained bleeding should be reported to your doctor promptly.

Q: Do I need to inform my dentist or surgeon that I’m taking Virata?
A: Yes, it’s important to inform any healthcare provider performing a procedure that you are taking this medicine, as temporary adjustments may be needed to reduce bleeding risk during surgery or dental work.

Q: What should I do if I miss a dose?
A: Take the missed dose as soon as you remember, unless it is close to the time for your next dose, in which case skip it. Do not double the dose to make up for a missed one, and consult your doctor if you have concerns.

Disclaimer

Always use this medicine strictly according to your doctor’s instructions and prescribed dosage.